Evolution of the Neuroinflammatory Response Over the Clinical Course of MS

Benjamin M. Segal, M.D., The Ohio State University, to present keynote address at ACTRIMS Forum 2021
22-Feb-2021 1:05 PM EST Add to Favorites

The Spectrum of Multiple Sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2021 Forum

Forum Announcement
19-Jan-2021 11:40 AM EST Add to Favorites

Q&A with Leaders of MS Virtual 2020 Conference

ACTRIMS MS Virtual 2020 Q&A with Association Leadership
16-Sep-2020 5:10 PM EDT Add to Favorites

Primary astrocytopathy has a detrimental effect on remyelination efficacy of parenchymal oligodendrocyte precursor cells

22-Sep-2020 9:50 AM EDT Add to Favorites

Phase 2 clinical trial evidence that a retinoid-X receptor agonist promotes remyelination in people with relapsing-remitting multiple sclerosis

22-Sep-2020 10:05 AM EDT Add to Favorites

Neutrophil granulocyte markers in cerebrospinal fluid differentiate NMOSD and anti-MOG antibody associated disease from MS in acute disease phase

22-Sep-2020 10:15 AM EDT Add to Favorites

Brain microstructural and metabolic alterations detected in vivo at the onset of the first demyelinating event

22-Sep-2020 10:30 AM EDT Add to Favorites

Network analysis identifies gut bacteria associated with multiple sclerosis relapse among pediatric-onset patients

22-Sep-2020 11:05 AM EDT Add to Favorites

See All News